RW Snyder, JS Berns - Seminars in Dialysis, 2004 - interscience.wiley.com Diabetes mellitus is recognized as a leading cause of chronic kidney disease
(CKD) and end-stage renal disease (ESRD) in the United States. There is a vast
array of medications used to treat diabetes, including insulin and the ... Cited by 36 - Related articles - BL Direct - All 3 versions
B Guerci, JP Sauvanet - Diabetes and Metabolism, 2005 - Elsevier The therapeutic goal in insulin-treated diabetic patients is to maintain on the
long-term a tight glucose control (HbA1 c < 6,5-7% or less) through an insulin
regimen which “mimic” the physiological insulin profile: a basal ... Cited by 34 - Related articles - BL Direct - All 3 versions
H Gin, H Hanaire-Broutin - Diabetes and Metabolism, 2005 - Elsevier Insulin-treated patients are generally taught to adapt their doses of insulin
according to the glycemic level obtained during self-tests. They usually adhere
to medical recommendations, but are often confused by the results, which ... Cited by 30 - Related articles - All 3 versions
G Biesenbach, A Raml, B Schmekal, G … - Diabetic Medicine, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 17 - Related articles - BL Direct - All 4 versions
JC Chan, R Scott, JC Arjona Ferreira, D … - Diabetes Obes Metab, 2008 - interscience.wiley.com Methods: In a 54-week, randomized, double-blind, parallel-group study, patients
with baseline glycosylated haemoglobin A 1c (HbA 1c ) values of 6.5–10% were
allocated (2:1) to sitagliptin (for 54 weeks) or the sequence of placebo ... Cited by 15 - Related articles - All 3 versions
J Loipl, B Schmekal, G Biesenbach - Renal failure, 2005 - informahealthcare.com There are only a few data in the literature concerning metabolic control in
insulin-treated diabetic patients with end stage renal disease (ESRD). The aim
of the study was to find out the long-term impact of hemodialysis on ... Cited by 8 - Related articles - All 5 versions
- ►oxfordjournals.org O Torffvit - Nephrology Dialysis Transplantation, 2003 - ERA-EDTA In the past there has been much discussion whether improved control of
hyperglycaemia translates into better cardiovascular and renal outcomes. Today
this has been proven both for type 1 diabetes in the DCCT (Diabetes Control ... Cited by 2 - Related articles - BL Direct - All 4 versions
L Heinemann - Endocrinology and Metabolism Clinics of North …, 2007 - Elsevier Future Directions for Insulin Therapy and Diabetes Treatment Lutz Heinemann, PhD
Chief Executive Officer of Business Development, Profil Institut fr
Stoffwechselforschung GmbH, Neuss, Germany The number of individuals with ... Cited by 1 - Related articles - All 3 versions
P Iglesias, JJ Diez - Diabetes, Obesity & Metabolism, 2008 - pt.wkhealth.com Diabetes mellitus (DM) is the main cause of end-stage renal disease (ESRD).
Conversely, chronic renal failure (CRF) is also associated with diverse
alterations in carbohydrate and insulin metabolism. CRF-induced metabolic ... Cited by 1 - Related articles - All 4 versions
